Table 1 Baseline characteristics
From: Predictors of adverse pathologic features after radical prostatectomy in low-risk prostate cancer
Variables (n = 546) | Median | IQR |
|---|---|---|
Age, year | 64 | 59–69 |
BMI, kg/m2 | 24.1 | 22.3–25.7 |
Year of operation (n/%) | ||
~ 2005 | 46 | 8.4 |
2006~ 2009 | 365 | 66.8 |
2010~ 2014 | 135 | 24.7 |
Type of operation (n/%) | ||
Open | 146 | 26.7 |
Robotic | 400 | 73.3 |
Prostate volume measured by TRUS, ml | 31.0 | 25.0–42.0 |
PSA, ng/ml | 5.6 | 4.5–7.0 |
Number of biopsy core | 12 | 12–12 |
Number of positive core | 2 | 1–3 |
Percentage of positive core, % | 16.7 | 8.3–25.0 |
Maximal percentage in each biopsy core, % | 30.0 | 10.0–50.0 |
Prostate volume in specimen, ml | 33.0 | 26–41.1 |
Tumor volume in specimen, ml | 0.8 | 0.3–1.8 |
Tumor / Prostate ratio | 0.03 | 0.01–0.06 |
Extracapsular extension (n/%) | 199 | 36.4 |
Seminal vesicle invasion (n/%) | 8 | 1.5 |
Positive surgical margin (n/%) | 179 | 32.8 |
GS after radical prostatectomy (n/%) | ||
GS 6 (3 + 3) | 336 | 61.5 |
GS 7 (3 + 4) | 143 | 26.2 |
GS 7 (4 + 3) | 48 | 8.8 |
GS 8 (4 + 4) | 13 | 2.4 |
GS 9 or 10 | 6 | 1.1 |
GS upgrading (n/%) | 210 | 38.5 |
Perineural invasion (n/%) | 175 | 32.1 |
Lymphovascular invasion (n/%) | 12 | 2.2 |
HGPIN (n/%) | 308 | 56.4 |